Bayer positions China as an innovation engine in its global healthcare strategy

Stefan Oelrich, member of the Board of Management of Bayer AG and head of its Pharmaceuticals Division. [Photo provided to chinadaily.com.cn]

Raccontata daglobal.chinadaily.com.cn